Abstract

Drug Utilization Review: Our Patients Deserve Our Very Best

Author(s): Jackson Kathleen

Issue: Nov/Dec 2023 - Volume 27, Number 6

Page(s): 450-453

Download in electronic PDF format for $75

Abstract

In 1990, the Omnibus Budget Reconciliation Act included requirements for Medicaid patients in an effort to save the federal government money. The requirements included a prospective drug utilization review, patient counseling, and maintenance of patient records. Subsequently, in 1993, when the pharmacy practice requirements went into effect, this federal regulation became the standard of care for pharmacists and part of their professional duty. This article suggests that the pharmacy should review all active pharmaceutical ingredients and excipients that are dispensed at the pharmacy and list all interactions or potential side effects in the review, so that a proper drug utilization review can be performed.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2023 Pg. 450-453	Drug Utilization Review: Our Patients Deserve Our Very Best Author(s): Jackson Kathleen
Jul/Aug 2012 Pg. 294-298	Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Author(s): Allen Loyd V Jr, Williams LaVonn A
May/Jun 2009 Pg. 224-229	Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education Author(s): McElhiney Linda F
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 350-351	PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Author(s): Allen Loyd V Jr, Williams LaVonn A
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 280-287	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Author(s): Allen Loyd V
Jul/Aug 2020 Pg. 296-297	Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Author(s): Brunner Scott
Mar/Apr 2015 Pg. 115-118	Bedside Manner: Not Just for Doctors Anymore Author(s): Cormier Mindy
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Mar/Apr 1997 Pg. 84-86	Compounding for the Pediatric Patient Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 258-263	Patient Satisfaction with Pharmacist Intervention and Consultation in HRT Author(s): DiMaggio Jennifer Lyn, Reed-Kane Dana
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
Mar/Apr 2015 Pg. 104-106	Standing Together Fixing the Drug Quality and Security Act Author(s): Miller David G
Nov/Dec 2021 Pg. 446-462	Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Author(s): Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Jan/Feb 2025 Pg. 33-36	Compounded GLP-1 Drugs and Patient Adverse Events Author(s): Alliance for Pharmacy Compounding
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Sep/Oct 2017 Pg. 373-380	Documentation: Records and Reports Author(s): Akers Michael J